Overview
Hemoglobin is an iron-containing protein found in red blood cells and is essential for transporting oxygen from the lungs to body tissues and carrying carbon dioxide back to the lungs for exhalation. It is composed of two main components: heme, which contains iron, and globin chains made of protein. The iron present in the heme group is critical for oxygen binding.
Structurally, hemoglobin is a tetramer consisting of four polypeptide chains. In adults, these are two alpha and two beta chains arranged as two identical alpha–beta dimers. Each polypeptide chain is linked to a heme group with a central iron atom. This quaternary structure allows cooperative binding of oxygen, meaning that binding of one oxygen molecule increases the affinity of the remaining binding sites. The hemoglobin test is a basic yet vital laboratory investigation used to assess oxygen-carrying capacity and overall blood health.
Symptoms
Abnormal hemoglobin levels do not directly cause symptoms but reflect underlying clinical conditions. Reduced hemoglobin levels are commonly associated with anemia and may present with fatigue, weakness, pallor, shortness of breath, dizziness, and palpitations.
Increased hemoglobin levels may be asymptomatic or cause symptoms related to increased blood viscosity, such as headache, dizziness, flushing, or an increased risk of thrombosis. The nature and severity of symptoms depend on the degree of hemoglobin abnormality and the underlying cause.
Causes
Low hemoglobin levels are most frequently caused by nutritional deficiencies, including iron, vitamin B12, and folate deficiency. Blood loss due to menstruation, gastrointestinal bleeding, trauma, surgery, or frequent blood donation is another major cause.
Bone marrow disorders such as aplastic anemia, leukemia, myelodysplastic syndromes, and bone marrow infiltration impair red blood cell production. Hemolytic anemias, including sickle cell disease, thalassemia, autoimmune hemolytic anemia, and enzyme deficiencies like G6PD deficiency, lead to premature destruction of red blood cells. Chronic conditions such as kidney disease, cancer, rheumatoid arthritis, and chronic infections or inflammation can also result in reduced hemoglobin levels.
Elevated hemoglobin levels are seen in dehydration, high-altitude living, and smoking. Primary polycythemia, such as polycythemia vera, results from intrinsic bone marrow overproduction of red blood cells. Secondary polycythemia occurs due to chronic lung disease, congenital heart disease, obstructive sleep apnea, or erythropoietin-secreting tumors. Hormonal therapies and anabolic steroid use may also increase hemoglobin levels.
Risk Factors
Risk factors for abnormal hemoglobin levels include poor dietary intake, chronic blood loss, pregnancy, chronic systemic illnesses, and inherited hemoglobin disorders. Pregnant women are particularly prone to anemia due to increased plasma volume, leading to dilutional anemia.
Children, elderly individuals, patients with chronic kidney disease, malignancies, autoimmune disorders, and those receiving chemotherapy are at increased risk of reduced hemoglobin levels. Smokers, individuals living at high altitude, and patients with chronic respiratory or cardiac diseases are more likely to have elevated hemoglobin levels.
Prevention
Prevention of abnormal hemoglobin levels focuses on early detection and correction of underlying causes. Adequate intake of iron, vitamin B12, and folate through diet or supplementation is essential for maintaining normal hemoglobin levels.
Routine screening in high-risk groups such as pregnant women, children, and patients with chronic illnesses allows early identification and timely intervention. Management of chronic diseases, prevention of unnecessary blood loss, and appropriate treatment of infections or systemic disorders help reduce the burden of hemoglobin-related abnormalities.
Clinical Importance and Interpretation
Hemoglobin estimation is a key component of the complete blood count and is widely used in clinical practice. It aids in the diagnosis and classification of anemia, evaluation of polycythemia, assessment of nutritional deficiencies, and monitoring of chronic diseases.
The test is routinely performed during pregnancy, preoperative evaluation, health check-ups, and in patients with respiratory or cardiac disorders to assess oxygen-carrying capacity. It is also essential for diagnosing hemoglobinopathies such as thalassemia and sickle cell disease.
Normal hemoglobin reference ranges vary with age, sex, and physiological status. Adult males generally have higher hemoglobin levels than females, while pregnant women and children have lower reference ranges. Results must always be interpreted in conjunction with clinical findings and other laboratory parameters.
Methods of Estimation and Limitations
Hemoglobin estimation can be performed using methods such as the cyanmethemoglobin method, Sahli’s acid hematin method, automated hematology analyzers, and portable point-of-care devices like HemoCue. Automated analyzers are most commonly used due to their accuracy, speed, and ability to provide results as part of a complete blood count.
Despite its importance, hemoglobin estimation alone cannot identify the underlying cause of anemia or polycythemia. Additional investigations are often required for definitive diagnosis. Results may also be influenced by hydration status, sample handling, and technical factors, highlighting the need for careful interpretation.
